According to him, European officials expect pharmaceutical companies to comply with the terms of the signed contracts. Otherwise, the EU is going to resort to legal proceedings.
At this point, it is known that Pfizer Company will temporarily reduce the volume of vaccine supplies to EU countries during the period of increase of its production capacities.
The company intends to increase production from 1.3 billion doses to 2 billion doses per year during this period of time.
As we reported earlier, AstraZeneca is going to cut deliveries of its coronavirus vaccine to the EU by 60% in the first quarter of the year due to production problems.
A spokesman for AstraZeneca said on Friday that "initial volumes will be lower than originally anticipated" without giving further details.
The drug firm was supposed to deliver about 80 million doses to the 27 nations by March.